Cammarata, E., Airoldi, C., Colombo, J., Ucciero, A., Mastorino, L., Arese, V., . . . Savoia, P. Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits. Mattioli1885.
Chicago Style (17th ed.) CitationCammarata, Edoardo, et al. Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits. Mattioli1885.
MLA (9th ed.) CitationCammarata, Edoardo, et al. Impact of Disease Activity-Guided Dose Reduction on IL-17 and IL-23 Inhibitors in Psoriasis: A Real-World Assessment of Efficacy, Safety, and Economic Benefits. Mattioli1885.
Warning: These citations may not always be 100% accurate.